会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 53. 发明申请
    • 心臓治療装置及び心臓治療方法
    • 心脏治疗装置和心脏治疗方法
    • WO2004105870A1
    • 2004-12-09
    • PCT/JP2004/007568
    • 2004-05-26
    • テルモ株式会社福井 美仁
    • 福井 美仁
    • A61N1/39
    • A61N1/3622A61N1/395A61N1/3956
    • 致死的不整脈の予防と治療を行うため、抗頻脈治療後の予防治療の制御を行うことが可能な心臓治療装置であり、頻脈の発生を検出した結果をもって頻脈予防手段及び頻脈治療手段(頻脈停止手段)を制御することにより抗頻脈治療を行う。この抗頻脈治療においては、カルジオバージョンや除細動などの心臓への電気ショックの供給後に、迷走神経に対する賦活電流、あるいは交感神経に対する抑制電流を低減もしくは停止する機構を備えているので、血行動態の悪化や致死的不整脈の再発、心房細動などの上室性不整脈の惹起を防ぐことができる。
    • 可以控制抗心律失常治疗后的预防治疗从而预防和治疗致命性心律失常的心脏治疗仪。 在该装置中,基于心动过速的检测结果来控制防止心动过速的手段和治疗心动过速的手段(停止心动过速的手段),从而进行抗心律失常治疗。 在这种抗心律失常疗法中,对心脏给予心律转复或除颤等电击,然后降低或停止迷走神经的活化电流或交感神经的抑制电流。 由于这种机制,可以防止血流动力学恶化,可以防止致命性心律失常复发或室性心律失常的诱导等室颤。
    • 57. 发明申请
    • A CARDIAC ARRHYTHMIA DETECTOR USING ECG WAVEFORM-FACTOR AND ITS IRREGULARITY
    • 使用ECG波形因子的CARDIAC ARRHYTHMIA检测器及其不正常
    • WO02002007A1
    • 2002-01-10
    • PCT/US2001/004006
    • 2001-02-08
    • A61B5/046A61B5/0464A61N1/39A61B5/04
    • A61N1/39A61B5/046A61B5/0464A61N1/36514A61N1/3925A61N1/395A61N1/3956
    • A cardiac monitor is provided that monitors the condition of the heart of a cardiac patient and generates signals indicating one of several conditions, such as supraventricular tachycardia, ventricular tachycardia (116) and ventricular fibrillation (118). In order to generate these signals, the ECG from the patient is analyzed to determine a certain interval and heart rate, as well as a waveform factor and a waveform factor irregularity. The waveform factor is derived from the average of the ECG amplitudes during a cardiac interval and the peak value of the ECG during the same interval. Preferably, a running average is calculated over several intervals. This waveform factor is then used to detect shockable ventricular arrhythmia. The waveform factor irregularity is indicative of the variability of the waveform factor and is used to differentiate between ventricular tachycardia and ventricular fibrillation.
    • 提供了一种监测心脏病患者心脏状况的心脏监测器,并产生指示若干病情之一的信号,例如室上性心动过速,室性心动过速(116)和心室颤动(118)。 为了产生这些信号,分析来自患者的ECG以确定一定的间隔和心率,以及波形因子和波形因子不规则性。 波形因子来自心脏间隔期间的ECG幅度的平均值,以及在相同间隔期间的ECG的峰值。 优选地,在几个间隔上计算运行平均值。 然后将该波形因子用于检测可震荡的室性心律失常。 波形因子不规则表示波形因子的变异性,用于区分室性心动过速和心室颤动。
    • 58. 发明申请
    • ATRIAL DEFIBRILLATION SYSTEM HAVING PATIENT SELECTABLE ATRIAL FIBRILLATION DETECTION
    • 具有患者选择性ATRIAL FIBRILLATION检测的ATRIAL DEFIBRILLATION系统
    • WO9952593A8
    • 2001-02-08
    • PCT/US9903168
    • 1999-02-12
    • CARDIAC PACEMAKERS INC
    • WHITE HARLEY G
    • A61N1/372A61N1/39
    • A61N1/3956A61N1/395
    • An atrial defibrillation system includes an implanted atrial defibrillator (30) having an atrial defibrillation detector (70) for detecting atrial fibrillation, and a cardioverter (76) for cardioverting the atria of a heart (16). The implanted atrial defibrillator (30) further includes a receiver (105) for receiving commands from an external non-implanted transmitter (100). A non-implanted communication device (110) includes a transmitter (116) for transmitting a command to the receiver (105). The command causes only the atrial fibrillation detector (70) to be activated resulting only in the detection for atrial fibrillation without committing to atrial fibrillation cardio-version should atrial fibrillation be detected.
    • 心房除颤系统包括具有用于检测心房纤维性颤动的心房除颤检测器(70)的植入式心房除颤器(30)和用于心脏转移心脏心房(16)的心律转复器(76)。 植入的心房除颤器(30)还包括用于从外部非植入式发射器(100)接收命令的接收器(105)。 非植入通信设备(110)包括用于向接收机(105)发送命令的发射机(116)。 该命令仅使心房纤维性颤动检测器(70)被激活,从而仅在心房颤动的检测中,而不致心房纤维颤动,心房颤动被检测。
    • 59. 发明申请
    • ATRIAL DEFIBRILLATION SYSTEM HAVING PATIENT SELECTABLE ATRIAL FIBRILLATION DETECTION
    • 具有患者选择性ATRIAL FIBRILLATION检测的ATRIAL DEFIBRILLATION系统
    • WO99052593A1
    • 1999-10-21
    • PCT/US1999/003168
    • 1999-02-12
    • A61N1/372A61N1/39
    • A61N1/3956A61N1/395
    • An atrial defibrillation system includes an implanted atrial defibrillator (30) having an atrial defibrillation detector (70) for detecting atrial fibrillation, and a cardioverter (76) for cardioverting the atria of a heart (16). The implanted atrial defibrillator (30) further includes a receiver (105) for receiving commands from an external non-implanted transmitter (100). A non-implanted communication device (110) includes a transmitter (116) for transmitting a command to the receiver (105). The command causes only the atrial fibrillation detector (70) to be activated resulting only in the detection for atrial fibrillation without committing to atrial fibrillation cardio-version should atrial fibrillation be detected.
    • 心房除颤系统包括具有用于检测心房纤维性颤动的心房除颤检测器(70)的植入式心房除颤器(30)和用于心脏转移心脏心房(16)的心律转复器(76)。 植入的心房除颤器(30)还包括用于从外部非植入式发射器(100)接收命令的接收器(105)。 非植入通信设备(110)包括用于向接收机(105)发送命令的发射机(116)。 该命令仅使心房纤维性颤动检测器(70)被激活,从而仅在心房颤动的检测中,而不致心房纤维颤动,心房颤动被检测。
    • 60. 发明申请
    • SYSTEM FOR TREATING SUPRAVENTRICULAR TACHYARRHYTHMIAS
    • 用于治疗子宫内膜异位症的系统
    • WO99047206A1
    • 1999-09-23
    • PCT/US1999/006083
    • 1999-03-19
    • A61N1/362A61N1/39
    • A61N1/3962A61N1/3622A61N1/395
    • A system and method for treating atrial fibrillation using atrial pacing pulses to convert an atrial fibrillation to non-fibrillation atrial arrhythmia prior to delivering a low energy cardioversion/defibrillation shock. The system and method treats atrial fibrillations by first applying a plurality of pacing pulses to the atria which converts the atrial fibrillation to non-fibrillation atrial arrhythmia. Ventricular intervals are concurrently sensed and analyzed while the plurality of electrical pacing pulses are being applied. Upon detecting a period of stable ventricular intervals, the system then proceeds to deliver a low-energy cardioverting/defibrillating pulse of electrical energy across the atria of the heart.
    • 一种用于在递送低能量心律转复/除颤休克之前使用心房起搏脉冲来治疗心房颤动以将心房颤动转换为非纤维性心房心律失常的系统和方法。 该系统和方法通过首先将多次起搏脉冲施加到将心房颤动转变为非纤维性心房心律不齐的心房来治疗房颤。 在施加多个起搏脉冲的同时,同时感测和分析心室间隔。 在检测到稳定的心室间隔的时间段时,系统然后继续在心脏的心房上提供电能的低能量心律转复/除颤脉冲。